Registration is now open for the Endometriosis Foundation of America’s (EFA) upcoming 2017 conference, “Breast, Ovary and Endometriosis.”
The one-day event on Oct. 28 will mark Breast Cancer Awareness Month by exploring the relationship between sex hormones and endometriosis, as well as its association with an increased risk of breast and ovarian cancer.
The conference will be held at Lotte New York Palace in New York City. The fee to participate for everyone except physicians and researchers is $100. Register for the event online here. More information about accommodations at the Lotte New York Palace can be found here.
The conference will start at 8 a.m. with a welcome session followed by an introduction to the EFA’s mission and history.
A session titled, “Estrogen from Inflammation to Cancer: A Distant Link?” will start at 9 a.m. and will include three presentations discussing the relationship between hormones, endometriosis, and breast cancer.
At 10:45 a.m., after a coffee break and some refreshments, a session titled, “DNA of Stem Cells: the Target and the Product,” will take place with presentations debating steroids, DNA, stem cells, and ovarian cancer.
The following session, “Cancer Mutations May Not Be Innocent Bystanders When Aroused by Sex Hormones,” starts at 1:15 p.m. and will include presentations and Q&A sessions addressing cancer implications for patients with endometriosis and the theoretical and practical relationship between hormones and the brain.
The 2:15 p.m. session titled, “Finding the Funds When Research is a Priority: Hope for Non-Government, Private Sector Money,” will address funding strategies of the National Institutes of Health (NIH) and EFA grants for estrogen, endometriosis, and breast cancer research.
Following a second coffee break, a session titled, “The Endpoint: Prevention for Cure,” at 3:20 p.m. will discuss the latest research on prophylactic mastectomy, breast reconstruction, and bilateral oophorectomy.
The session, “Pausing Mortality for the Miracle of Life,” will start at 3:50 p.m. and address fertility and BRCA mutations. At 4:20 p.m., a panel discussion will focus on these topics with Monica Halem, a New York dermatologist who will discuss in vitro fertilization (IVF).
A closing session at 5 p.m. titled, “Future Direction,” will address the common risk factors and hormonal accelerates for breast and ovarian cancers and endometriosis.
If you are considering attending the conference but would like to arrive before Oct. 27 or extend your stay past Oct. 28, you can call the reservations department at the Lotte New York Palace Hotel at 1-800-NY-PALACE (1-800-697-2522) for information on room rates.